Cargando…
Design, Development, Physicochemical Characterization, and In Vitro Drug Release of Formoterol PEGylated PLGA Polymeric Nanoparticles
Polymeric nanoparticles’ drug delivery systems represent a promising platform for targeted controlled release since they are capable of improving the bioavailability and tissue localization of drugs compared to traditional means of administration. Investigation of key parameters of nanoparticle prep...
Autores principales: | Vallorz, Ernest L., Encinas-Basurto, David, Schnellmann, Rick G., Mansour, Heidi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955426/ https://www.ncbi.nlm.nih.gov/pubmed/35336011 http://dx.doi.org/10.3390/pharmaceutics14030638 |
Ejemplares similares
-
Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release
por: Encinas-Basurto, David, et al.
Publicado: (2022) -
Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol
por: Cameron, Robert B., et al.
Publicado: (2017) -
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
por: Sánchez-López, Elena, et al.
Publicado: (2018) -
Author Correction: Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol
por: Cameron, Robert B., et al.
Publicado: (2019) -
Development, optimization, and evaluation of PEGylated brucine-loaded PLGA
nanoparticles
por: Elsewedy, Heba S., et al.
Publicado: (2020)